|
| (+)-4-[2-HYDROXY-3-[(1-METHYLETHYL)-AMINO]PROPOXY]BENZENEACETAMIDE Basic information |
Product Name: | (+)-4-[2-HYDROXY-3-[(1-METHYLETHYL)-AMINO]PROPOXY]BENZENEACETAMIDE | Synonyms: | 4-[(R)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide;2-[4-[(2R)-2-hydroxy-3-(isopropylamino)propoxy]phenyl]acetamide;2-[4-[(2R)-2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide;2-[4-[(2R)-2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]ethanamide;(R)-(+)-Atenolol,(+)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide;R(+)-ATENOLOL LESS ACTIVE ENANTIOME;Benzeneacetamide, 4-[(2R)-2-hydroxy-3-[(1-methylethyl)amino]propoxy]-;Benzeneacetamide, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-, (R)- | CAS: | 56715-13-0 | MF: | C14H22N2O3 | MW: | 266.34 | EINECS: | | Product Categories: | Amines;Aromatics;Intermediates & Fine Chemicals;Pharmaceuticals | Mol File: | 56715-13-0.mol | |
| (+)-4-[2-HYDROXY-3-[(1-METHYLETHYL)-AMINO]PROPOXY]BENZENEACETAMIDE Chemical Properties |
Melting point | 148-152 °C(lit.) | Boiling point | 508.0±50.0 °C(Predicted) | density | 1.125±0.06 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: >6.0 mg/mL | pka | 13.88±0.20(Predicted) | form | solid | color | pale yellow | optical activity | [α]25/D +16°, c = 1 in 1 M HCl |
| (+)-4-[2-HYDROXY-3-[(1-METHYLETHYL)-AMINO]PROPOXY]BENZENEACETAMIDE Usage And Synthesis |
Description | (+)-Atenolol is an enantiomer of the β1-adrenergic receptor (β1-AR) antagonist (±)-atenolol . (+)-Atenolol inhibits radioligand binding to β-ARs on sarcolemma-enriched membranes (Ki = 8.61 μM). Unlike (–)-atenolol and (±)-antenolol, (+)-atenolol has no effect on blood pressure in spontaneously hypertensive rats. | Uses | less active enantiomer | Uses | Antihypertensor | Uses | Cardioselective β-adrenergic blocker. Antihypertensive, antianginal, antiarrhythmic (class II). | Definition | ChEBI: The (R)-enantiomer of atenolol. | references | [1] stoschitzky k, egginger g, zernig g, et al. stereoselective features of (r)- and (s)-atenolol: clinical pharmacological, pharmacokinetic, and radioligand binding studies[j]. chirality, 1993, 5(1): 15-19. |
| (+)-4-[2-HYDROXY-3-[(1-METHYLETHYL)-AMINO]PROPOXY]BENZENEACETAMIDE Preparation Products And Raw materials |
|